NO974498L - Monomere insulinanalogformuleringer - Google Patents
Monomere insulinanalogformuleringerInfo
- Publication number
- NO974498L NO974498L NO974498A NO974498A NO974498L NO 974498 L NO974498 L NO 974498L NO 974498 A NO974498 A NO 974498A NO 974498 A NO974498 A NO 974498A NO 974498 L NO974498 L NO 974498L
- Authority
- NO
- Norway
- Prior art keywords
- approx
- insulin analog
- physiologically acceptable
- analog formulations
- monomer insulin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/62—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Abstract
Foreliggende oppfinnelse beskriver forskjellige parenterale farmasøytiske formuleringer som har en langvarig effekt, og omfatter en steril vandig suspensjon av ca. 20 U/ml til ca. 500 U/ml insulinanalog, ca. 5 mg/ml til ca. 10 mg/ml natriumklorid, ca. 0,2 til ca. 2,0 mg/ml fysiologisk akseptabel buffer, et sinkioneinnhold på ca. 0,07 mg/ml til ca. 0,1 mg/ml, og et fysiologisk akseptabelt preservativ ved en pH på ca. 6,5 til ca. 7,8; slik at mindre enn 5% av analogen som er tilstede i suspensjonen er i oppløst tilstand.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US41488095A | 1995-03-31 | 1995-03-31 | |
PCT/US1996/004424 WO1996030040A1 (en) | 1995-03-31 | 1996-03-28 | Monomeric insulin analog formulations |
Publications (2)
Publication Number | Publication Date |
---|---|
NO974498D0 NO974498D0 (no) | 1997-09-29 |
NO974498L true NO974498L (no) | 1997-10-08 |
Family
ID=23643384
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO974498A NO974498L (no) | 1995-03-31 | 1997-09-29 | Monomere insulinanalogformuleringer |
Country Status (23)
Country | Link |
---|---|
US (1) | US5952297A (no) |
EP (1) | EP0735048A1 (no) |
JP (1) | JPH11502856A (no) |
KR (1) | KR19980703425A (no) |
CN (1) | CN1185114A (no) |
AR (1) | AR002976A1 (no) |
AU (1) | AU720300B2 (no) |
BR (1) | BR9607935A (no) |
CA (1) | CA2216516A1 (no) |
CO (1) | CO4700482A1 (no) |
CZ (1) | CZ305297A3 (no) |
EA (1) | EA000970B1 (no) |
HU (1) | HUP9801700A3 (no) |
IL (1) | IL117696A (no) |
MX (1) | MX9707428A (no) |
NO (1) | NO974498L (no) |
NZ (1) | NZ305719A (no) |
PE (1) | PE38797A1 (no) |
PL (1) | PL322626A1 (no) |
TR (1) | TR199701078T1 (no) |
WO (1) | WO1996030040A1 (no) |
YU (1) | YU18596A (no) |
ZA (1) | ZA962502B (no) |
Families Citing this family (73)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PE79099A1 (es) * | 1997-06-13 | 1999-08-24 | Lilly Co Eli | Formulaciones de insulina estables |
SI0884053T1 (en) * | 1997-06-13 | 2003-02-28 | Eli Lilly And Company | Stable insulin formulations |
US20010053761A1 (en) * | 1998-01-08 | 2001-12-20 | Dimarchi Richard Dennis | Method for administering aspb28-human insulin |
AU2827199A (en) * | 1998-03-24 | 1999-10-18 | Klavs Holger Jorgensen | Novel preparation of protracted acting human insulin |
US6211144B1 (en) * | 1998-10-16 | 2001-04-03 | Novo Nordisk A/S | Stable concentrated insulin preparations for pulmonary delivery |
US7169889B1 (en) * | 1999-06-19 | 2007-01-30 | Biocon Limited | Insulin prodrugs hydrolyzable in vivo to yield peglylated insulin |
CN1125081C (zh) | 1999-09-08 | 2003-10-22 | 中国科学院上海生物化学研究所 | 重组天然和新型人胰岛素及其制备方法 |
US6734162B2 (en) | 2000-01-24 | 2004-05-11 | Minimed Inc. | Mixed buffer system for stabilizing polypeptide formulations |
WO2002051428A1 (fr) * | 2000-12-25 | 2002-07-04 | Shiseido Company, Ltd. | Composition de parfum stimulant le systeme sympathique |
ES2278020T3 (es) * | 2001-02-09 | 2007-08-01 | Genentech, Inc. | Cristalizacion de igf-1. |
US7713932B2 (en) | 2001-06-04 | 2010-05-11 | Biocon Limited | Calcitonin drug-oligomer conjugates, and uses thereof |
US6713452B2 (en) | 2001-06-04 | 2004-03-30 | Nobex Corporation | Mixtures of calcitonin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same |
US6828297B2 (en) | 2001-06-04 | 2004-12-07 | Nobex Corporation | Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same |
US6828305B2 (en) | 2001-06-04 | 2004-12-07 | Nobex Corporation | Mixtures of growth hormone drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same |
US6737401B2 (en) | 2001-06-28 | 2004-05-18 | Metronic Minimed, Inc. | Methods of evaluating protein formulation stability and surfactant-stabilized insulin formulations derived therefrom |
US6913903B2 (en) * | 2001-09-07 | 2005-07-05 | Nobex Corporation | Methods of synthesizing insulin polypeptide-oligomer conjugates, and proinsulin polypeptide-oligomer conjugates and methods of synthesizing same |
US7166571B2 (en) * | 2001-09-07 | 2007-01-23 | Biocon Limited | Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same |
US6770625B2 (en) | 2001-09-07 | 2004-08-03 | Nobex Corporation | Pharmaceutical compositions of calcitonin drug-oligomer conjugates and methods of treating diseases therewith |
US7312192B2 (en) * | 2001-09-07 | 2007-12-25 | Biocon Limited | Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same |
US7030082B2 (en) * | 2001-09-07 | 2006-04-18 | Nobex Corporation | Pharmaceutical compositions of drug-oligomer conjugates and methods of treating disease therewith |
US7683029B2 (en) * | 2003-05-07 | 2010-03-23 | Philip Morris Usa Inc. | Liquid aerosol formulations containing insulin and aerosol generating devices and methods for generating aerosolized insulin |
RU2393168C2 (ru) | 2004-07-19 | 2010-06-27 | Биокон Лимитед | Инсулин-олигомерные конъюгаты, их препараты и применения |
US7597884B2 (en) | 2004-08-09 | 2009-10-06 | Alios Biopharma, Inc. | Hyperglycosylated polypeptide variants and methods of use |
US7833513B2 (en) | 2004-12-03 | 2010-11-16 | Rhode Island Hospital | Treatment of Alzheimer's Disease |
WO2007121318A2 (en) | 2006-04-12 | 2007-10-25 | Emisphere Technologies, Inc. | Formulations for delivering insulin |
EP2203181B1 (en) | 2007-10-16 | 2018-02-14 | Biocon Limited | An orally administerable solid pharmaceutical composition and a process thereof |
JP2011506442A (ja) * | 2007-12-11 | 2011-03-03 | コンジュケム バイオテクノロジーズ インコーポレイテッド | インスリン分泌性ペプチド結合体の製剤 |
EP2077132A1 (en) | 2008-01-02 | 2009-07-08 | Boehringer Ingelheim Pharma GmbH & Co. KG | Dispensing device, storage device and method for dispensing a formulation |
MY152979A (en) | 2008-01-09 | 2014-12-15 | Sanofi Aventis Deutschland | Novel insulin derivatives having an extremely delayed time-action profile |
WO2010028175A1 (en) | 2008-09-08 | 2010-03-11 | The Board Of Trustees Of The Leland Stanford Junior University | Modulators of aldehyde dehydrogenase activity and methods of use thereof |
LT2349324T (lt) | 2008-10-17 | 2017-12-27 | Sanofi-Aventis Deutschland Gmbh | Insulino ir glp-1 agonisto derinys |
CN102202669A (zh) | 2008-10-28 | 2011-09-28 | 利兰·斯坦福青年大学托管委员会 | 醛脱氢酶调节剂及其使用方法 |
JP5508438B2 (ja) | 2009-01-28 | 2014-05-28 | スマートセルズ・インコーポレイテツド | 制御された薬物送達のための複合体に基づくシステム |
CA2750252A1 (en) | 2009-01-28 | 2010-08-05 | Smartcells, Inc. | Synthetic conjugates and uses thereof |
CN102316892B (zh) | 2009-02-12 | 2014-06-04 | 西马生物医学计划公司 | 心肌营养素-1用于治疗代谢病的用途 |
CA2754950A1 (en) | 2009-03-20 | 2010-09-23 | Smartcells, Inc. | Terminally-functionalized conjugates and uses thereof |
JP5670421B2 (ja) | 2009-03-31 | 2015-02-18 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | コンポーネント表面のコーティング方法 |
EP2432531B1 (de) | 2009-05-18 | 2019-03-06 | Boehringer Ingelheim International GmbH | Adapter, inhalationseinrichtung und zerstäuber |
TWI468171B (zh) | 2009-11-13 | 2015-01-11 | Sanofi Aventis Deutschland | 含glp-1激動劑及甲硫胺酸之醫藥組成物 |
ES2855146T3 (es) | 2009-11-13 | 2021-09-23 | Sanofi Aventis Deutschland | Composición farmacéutica que comprende un agonista de GLP-1, una insulina y metionina |
MX2012005961A (es) | 2009-11-25 | 2012-06-14 | Boehringer Ingelheim Int | Nebulizador. |
US10016568B2 (en) | 2009-11-25 | 2018-07-10 | Boehringer Ingelheim International Gmbh | Nebulizer |
JP5658268B2 (ja) | 2009-11-25 | 2015-01-21 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | ネブライザ |
AU2011202239C1 (en) | 2010-05-19 | 2017-03-16 | Sanofi | Long-acting formulations of insulins |
WO2011160932A1 (en) | 2010-06-24 | 2011-12-29 | Boehringer Ingelheim International Gmbh | Nebulizer |
CN103179978A (zh) | 2010-08-30 | 2013-06-26 | 赛诺菲-安万特德国有限公司 | Ave0010用于制造供治疗2型糖尿病用的药物的用途 |
EP2694220B1 (de) | 2011-04-01 | 2020-05-06 | Boehringer Ingelheim International GmbH | Medizinisches gerät mit behälter |
US10457659B2 (en) | 2011-04-29 | 2019-10-29 | The Board Of Trustees Of The Leland Stanford Junior University | Compositions and methods for increasing proliferation of adult salivary stem cells |
US9821032B2 (en) | 2011-05-13 | 2017-11-21 | Sanofi-Aventis Deutschland Gmbh | Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin |
US9827384B2 (en) | 2011-05-23 | 2017-11-28 | Boehringer Ingelheim International Gmbh | Nebulizer |
JP6367115B2 (ja) | 2011-08-29 | 2018-08-01 | サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | 2型糖尿病患者の血糖コントロールに使用する組合せ医薬 |
AR087744A1 (es) | 2011-09-01 | 2014-04-16 | Sanofi Aventis Deutschland | Composicion farmaceutica para uso en el tratamiento de una enfermedad neurodegenerativa |
WO2013152894A1 (de) | 2012-04-13 | 2013-10-17 | Boehringer Ingelheim International Gmbh | Zerstäuber mit kodiermitteln |
US9707276B2 (en) | 2012-12-03 | 2017-07-18 | Merck Sharp & Dohme Corp. | O-glycosylated carboxy terminal portion (CTP) peptide-based insulin and insulin analogues |
WO2014160185A2 (en) | 2013-03-14 | 2014-10-02 | The Board Of Trustees Of The Leland Stanford Junior University | Mitochondrial aldehyde dehydrogenase-2 modulators and methods of use thereof |
RU2019133674A (ru) | 2013-04-03 | 2020-05-20 | Санофи | Лечение сахарного диабета с помощью составов инсулинов длительного действия |
EP2835146B1 (en) | 2013-08-09 | 2020-09-30 | Boehringer Ingelheim International GmbH | Nebulizer |
EP3030298B1 (en) | 2013-08-09 | 2017-10-11 | Boehringer Ingelheim International GmbH | Nebulizer |
EP3077414B1 (en) | 2013-12-04 | 2020-06-17 | Merck Sharp & Dohme Corp. | Method for preparing crystalline insulin |
SI3928818T1 (sl) | 2014-05-07 | 2023-04-28 | Boehringer Ingelheim International Gmbh | Razpršilnik in vsebnik |
DK3139979T3 (da) | 2014-05-07 | 2023-10-09 | Boehringer Ingelheim Int | Enhed, forstøver og fremgangsmåde |
ES2874029T3 (es) | 2014-05-07 | 2021-11-04 | Boehringer Ingelheim Int | Nebulizador |
BR112017000175B1 (pt) * | 2014-07-08 | 2023-11-21 | Amphastar Pharmaceuticals,Inc. | Método de preparação de uma insulina inalável adequada para a liberação pulmonar e partículas de insulina micronizadas |
WO2016032869A1 (en) | 2014-08-26 | 2016-03-03 | Merck Sharp & Dohme Corp. | Method for preparing crystalline insulin or insulin analog compositions |
CR20170314A (es) | 2014-12-12 | 2017-10-20 | Sanofi Aventis Deutschland | Formulación de relación fija de insulina glargina/lixisenatida |
TWI748945B (zh) | 2015-03-13 | 2021-12-11 | 德商賽諾菲阿凡提斯德意志有限公司 | 第2型糖尿病病患治療 |
TW201705975A (zh) | 2015-03-18 | 2017-02-16 | 賽諾菲阿凡提斯德意志有限公司 | 第2型糖尿病病患之治療 |
US10322168B2 (en) | 2016-01-07 | 2019-06-18 | Amphastar Pharmaceuticals, Inc. | High-purity inhalable particles of insulin and insulin analogues, and high-efficiency methods of manufacturing the same |
WO2019125878A1 (en) | 2017-12-18 | 2019-06-27 | Merck Sharp & Dohme Corp. | Conjugate based systems for controlled insulin delivery |
EP3740212A4 (en) | 2017-12-18 | 2021-10-27 | Merck Sharp & Dohme Corp. | CONJUGATE-BASED SYSTEMS FOR CONTROLLED INSULIN DELIVERY |
WO2021202802A1 (en) | 2020-03-31 | 2021-10-07 | Protomer Technologies Inc. | Conjugates for selective responsiveness to vicinal diols |
EP4247429A1 (en) | 2020-11-19 | 2023-09-27 | Protomer Technologies Inc. | Aromatic boron-containing compounds and insulin analogs |
WO2023225534A1 (en) | 2022-05-18 | 2023-11-23 | Protomer Technologies Inc. | Aromatic boron-containing compounds and related insulin analogs |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2626228A (en) * | 1945-05-17 | 1953-01-20 | Novo Terapeutisk Labor As | Method of producing crystalline insulin |
US2882202A (en) * | 1950-04-05 | 1959-04-14 | Novo Terapeutisk Labor As | Insulin crystal preparations and methods of producing them |
US2648622A (en) * | 1950-11-29 | 1953-08-11 | Research Corp | Purifying insulin by seeding with unclumped fibrils of insulin |
US2882203A (en) * | 1951-06-26 | 1959-04-14 | Novo Terapeutisk Labor As | Injectable insulin preparation with protracted effect |
DK78069C (da) * | 1952-06-23 | 1954-09-06 | Novo Terapeutisk Labor As | Fremgangsmåde til fremstilling af krystallinsk insulin. |
US2849370A (en) * | 1953-06-04 | 1958-08-26 | Novo Terapeutisk Labortorium A | Injectable insulin preparations with protracted effect and process of producing same |
US3102077A (en) * | 1953-08-19 | 1963-08-27 | Christensen Henry Marinus | Preparation of insulin containing 2.75 to 8 percent zinc content |
US2819999A (en) * | 1953-11-13 | 1958-01-14 | Novo Terapeutisk Labor As | Process for crystallization of insulin using freeze dried insulin as seeding material |
US2799622A (en) * | 1953-11-14 | 1957-07-16 | Novo Terapeutisk Labor As | Process of producing insulin crystals of substantially uniform size and compositions thereof |
US3060093A (en) * | 1957-07-18 | 1962-10-23 | Nordisk Insulinlab | Slowly acting insulin preparation in crystalline form and method of preparation |
AT304760B (de) * | 1969-08-08 | 1973-01-25 | Novo Terapeutisk Labor As | Verfahren zur Reinigung von Insulin |
DE2933946A1 (de) * | 1979-08-22 | 1981-03-12 | Hoechst Ag, 6000 Frankfurt | Insulinkristallsuspension und verfahren zu ihrer herstellung. |
FI78616C (fi) * | 1982-02-05 | 1989-09-11 | Novo Industri As | Foerfarande foer framstaellning av en foer infusionsaendamaol avsedd stabiliserad insulinloesning, som har en foerhoejd zinkhalt. |
DE3327709A1 (de) * | 1983-07-29 | 1985-02-07 | Hoechst Ag, 6230 Frankfurt | Insulin-derivat-kristallsuspensionen, verfahren zu deren herstellung und deren verwendung |
PH25772A (en) * | 1985-08-30 | 1991-10-18 | Novo Industri As | Insulin analogues, process for their preparation |
PH23446A (en) * | 1986-10-20 | 1989-08-07 | Novo Industri As | Peptide preparations |
DE3827533A1 (de) * | 1988-08-13 | 1990-02-15 | Hoechst Ag | Pharmazeutische zubereitung zur behandlung des diabetes mellitus |
US5514646A (en) * | 1989-02-09 | 1996-05-07 | Chance; Ronald E. | Insulin analogs modified at position 29 of the B chain |
US5534488A (en) * | 1993-08-13 | 1996-07-09 | Eli Lilly And Company | Insulin formulation |
US5461031A (en) * | 1994-06-16 | 1995-10-24 | Eli Lilly And Company | Monomeric insulin analog formulations |
AU711428B2 (en) * | 1994-06-16 | 1999-10-14 | Eli Lilly And Company | Monomeric insulin analog formulations |
US5504188A (en) * | 1994-06-16 | 1996-04-02 | Eli Lilly And Company | Preparation of stable zinc insulin analog crystals |
US5474978A (en) * | 1994-06-16 | 1995-12-12 | Eli Lilly And Company | Insulin analog formulations |
-
1996
- 1996-03-27 AR ARP960101937A patent/AR002976A1/es not_active Application Discontinuation
- 1996-03-27 YU YU18596A patent/YU18596A/sh unknown
- 1996-03-28 AU AU53812/96A patent/AU720300B2/en not_active Ceased
- 1996-03-28 HU HU9801700A patent/HUP9801700A3/hu unknown
- 1996-03-28 CZ CZ973052A patent/CZ305297A3/cs unknown
- 1996-03-28 JP JP8529728A patent/JPH11502856A/ja active Pending
- 1996-03-28 IL IL11769696A patent/IL117696A/xx not_active IP Right Cessation
- 1996-03-28 PE PE1996000217A patent/PE38797A1/es not_active Application Discontinuation
- 1996-03-28 CO CO96015449A patent/CO4700482A1/es unknown
- 1996-03-28 KR KR1019970706829A patent/KR19980703425A/ko not_active Application Discontinuation
- 1996-03-28 EP EP96302171A patent/EP0735048A1/en not_active Withdrawn
- 1996-03-28 WO PCT/US1996/004424 patent/WO1996030040A1/en not_active Application Discontinuation
- 1996-03-28 ZA ZA9602502A patent/ZA962502B/xx unknown
- 1996-03-28 NZ NZ305719A patent/NZ305719A/en unknown
- 1996-03-28 BR BR9607935A patent/BR9607935A/pt not_active Application Discontinuation
- 1996-03-28 CN CN96194052A patent/CN1185114A/zh active Pending
- 1996-03-28 MX MX9707428A patent/MX9707428A/es unknown
- 1996-03-28 PL PL96322626A patent/PL322626A1/xx unknown
- 1996-03-28 TR TR97/01078T patent/TR199701078T1/xx unknown
- 1996-03-28 EA EA199700285A patent/EA000970B1/ru not_active IP Right Cessation
- 1996-03-28 CA CA002216516A patent/CA2216516A1/en not_active Abandoned
-
1997
- 1997-09-26 US US08/938,245 patent/US5952297A/en not_active Expired - Fee Related
- 1997-09-29 NO NO974498A patent/NO974498L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CN1185114A (zh) | 1998-06-17 |
AR002976A1 (es) | 1998-05-27 |
IL117696A (en) | 2000-01-31 |
JPH11502856A (ja) | 1999-03-09 |
EA199700285A1 (ru) | 1998-02-26 |
ZA962502B (en) | 1997-09-29 |
EA000970B1 (ru) | 2000-08-28 |
IL117696A0 (en) | 1996-07-23 |
KR19980703425A (ko) | 1998-11-05 |
PE38797A1 (es) | 1997-10-04 |
US5952297A (en) | 1999-09-14 |
HUP9801700A3 (en) | 1998-12-28 |
PL322626A1 (en) | 1998-02-02 |
YU18596A (sh) | 1998-07-10 |
CO4700482A1 (es) | 1998-12-29 |
NZ305719A (en) | 1998-09-24 |
HUP9801700A2 (hu) | 1998-11-30 |
AU720300B2 (en) | 2000-05-25 |
BR9607935A (pt) | 1998-06-02 |
AU5381296A (en) | 1996-10-16 |
WO1996030040A1 (en) | 1996-10-03 |
MX9707428A (es) | 1997-12-31 |
CZ305297A3 (cs) | 1998-02-18 |
CA2216516A1 (en) | 1996-10-03 |
EP0735048A1 (en) | 1996-10-02 |
TR199701078T1 (xx) | 1998-01-21 |
NO974498D0 (no) | 1997-09-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO974498L (no) | Monomere insulinanalogformuleringer | |
EP1234586A3 (en) | Hepatoselective pharmaceutical actives | |
JO3404B1 (ar) | تركيبة صيدلانية سائلة تحتوي على مشتقات اريثروبويتين | |
DE69520768D1 (de) | Pharmazeutische Zubereitungen, die Fluoxetin enthalten | |
CA2478621A1 (en) | Botulinum toxin pharmaceutical compositions | |
ES2160693T3 (es) | Formulacion estable de 10-hidroxi-7-etil-camptotecina en la forma lactona. | |
MX9710206A (es) | Composicion farmaceutica de amiodarone para administracion parenteral. | |
WO1996024370B1 (en) | Pharmaceutical non inorganic saline solutions for endonasal administration of a calcitonin | |
NO971683L (no) | Lyofilisert farmasöytisk preparat som gjör vandige medikamentblandinger reversibelt termogelatinerende | |
US4256743A (en) | Inhibition of bone resorption with H1 -blocking antihistamines | |
IT1256702B (it) | Formulazione proteica coadiuvante nella prevenzione e cura delle parodontiti e di altre patologie batteriche del cavo orale. | |
MX9205568A (es) | Composicion farmaceutica que contiene cantidades de 5-amino-1beta-d-ribofuranosil-imidazol-4-carboxamida. | |
AU690794B2 (en) | Anti-inflammatory eyedrops | |
GR3002835T3 (en) | Pharmaceutical compositions containing pentamidine | |
HUP9903410A2 (hu) | Tolfenámsavat vagy gyógyszerészetileg elfogadható sóját tartalmazó, gyors hatóanyag-leadású tabletta | |
KR910005886A (ko) | 안정화 백혈구 인터페론 | |
TH25940A (th) | สารสูตรผสม มอนอเมอริค อินซูลิน อานาลอค | |
TH25940B (th) | สารสูตรผสม มอนอเมอริค อินซูลิน อานาลอค | |
KR910019636A (ko) | 에리트로포이에틴의 수성 약학적제제 및 이의 용도 | |
RU2000112924A (ru) | Применение глюкозаминоглюканов для получения фармацевтических препаратов для лечения связанных с диабетом глазных болезней | |
鹿金龙 | The Famine in Ethiopia | |
TH37164A (th) | สารผสมเภสัชกรรม |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |